TOPIC
Creating a Healthier Asia
+ FOLLOW
Paid Post:
Gilead Sciences
Creating a Healthier Asia
Stories that show how biopharmaceutical company Gilead Sciences works with governments, communities and healthcare professionals in Asia to eliminate chronic diseases such as hepatitis B, hepatitis C, human immunodeficiency virus (HIV) and Covid-19.
SHOW FULL PROFILE
last updated:
24 August, 2022
Are weight loss camps the answer to China's obesity crisis?
Health experts call for more industry regulation as weight loss camps boom in China
29 Nov 2024 - 11:24AM
Hard lessons from the Covid-19 pandemic: patients-first collaboration proves critical
Paid Post:
Gilead Sciences
‘Mistaken beliefs’ fuel Asia’s prejudice against people with HIV
In partnership with:
Gilead Sciences
Morning Studio
Taiwan targets blood-borne ‘silent killer’ hepatitis C
Island’s health education and targeted screening – backed by Gilead Sciences’ research – aims to halt 90 per cent of infections and 65 per cent of HCV deaths by 2025
14 Jan 2022 - 11:14AM
videocam
Gilead Sciences
Why most people with hepatitis B have no idea they have the disease
Most people infected with serious liver infection caused by hepatitis B virus are unaware they have it, yet early diagnosis and treatment can stop it becoming chronic liver disease
In partnership with:
Gilead Sciences
Advertisement
Advertisement
Advertisement
Advertisement